Sensei Biotherapeutics (NASDAQ:SNSE) Trading Up 0.9% – Here’s Why

Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) were up 0.9% during mid-day trading on Thursday . The company traded as high as $12.40 and last traded at $9.46. Approximately 247,695 shares were traded during mid-day trading, an increase of 281% from the average daily volume of 65,094 shares. The stock had previously closed at $9.38.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on SNSE shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Sensei Biotherapeutics in a research report on Wednesday, October 8th. HC Wainwright downgraded Sensei Biotherapeutics from a “buy” rating to a “neutral” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Sensei Biotherapeutics has an average rating of “Moderate Buy” and a consensus target price of $55.00.

Sensei Biotherapeutics Stock Up 0.9%

The stock has a 50-day simple moving average of $9.72 and a two-hundred day simple moving average of $8.33. The firm has a market cap of $11.92 million, a PE ratio of -0.44 and a beta of 0.31.

Sensei Biotherapeutics (NASDAQ:SNSE) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($3.91) earnings per share for the quarter, beating analysts’ consensus estimates of ($6.20) by $2.29. Research analysts expect that Sensei Biotherapeutics, Inc. will post -1.17 earnings per share for the current year.

About Sensei Biotherapeutics

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.